Carbamazepine
Cities measured
87
Detected in
87 / 87
Elevated / alert
1
Highest
0.38 μg/L — Cairo
Overview
Carbamazepine is an anticonvulsant and mood-stabilising drug. It is one of the most persistent pharmaceuticals in aquatic environments — conventional biological wastewater treatment removes < 10%. It is used as a 'pharmaceutical tracer' by environmental scientists because its presence reliably indicates urban wastewater.
Health Relevance
At environmental concentrations (ng/L), no acute effects in humans. At μg/L concentrations, developmental and reproductive toxicity is observed in zebrafish studies.
Regulatory Limits
Drinking Water Directive 2020/2184
No EU drinking water limit.
Controversy & Contested Science
Carbamazepine has been detected in drinking water in Germany, UK, US, and Israel at 10–100 ng/L. Its ubiquity is evidence that current wastewater treatment infrastructure was designed for nutrients and pathogens — not for pharmaceutical removal. Critics argue a watch-list approach without binding limits allows perpetual postponement of action. Advanced treatment (ozonation + activated carbon) is effective but requires €500M+ capital investment per major utility — costs that are being resisted or deferred across the EU.